Table 1 Statistical correlation between B4GALT5 and clinicopathological parameters
From: B4GALT5 high expression associated with poor prognosis of hepatocellular carcinoma
Clinical | Group | No. | B4GALT5 median | P-value |
|---|---|---|---|---|
TCGA | Â | Â | Â | Â |
age | >=60 | 175 | 4.453 | 0.442 |
| Â | <60 | 160 | 4.536 | Â |
gender | F | 108 | 4.689 | 0.0117 |
| Â | M | 227 | 4.399 | Â |
race | asian | 155 | 4.511 | 0.0525 |
| Â | black | 14 | 4.397 | Â |
| Â | white | 164 | 3.673 | Â |
stage | I-II | 247 | 4.381 | 0.0004 |
| Â | III-IV | 88 | 4.807 | Â |
GSE14520 | Â | Â | Â | Â |
age | >=60 | 43 | 6.994 | 0.151 |
| Â | <60 | 178 | 7.186 | Â |
gender | F | 30 | 7.246 | 0.469 |
| Â | M | 191 | 7.133 | Â |
stage | I-II | 170 | 7.094 | 0.072 |
| Â | III-IV | 49 | 7.322 | Â |
ALT | high | 91 | 7.262 | 0.072 |
| Â | low | 130 | 7.069 | Â |
AFP | high | 101 | 7.264 | 0.038 |
| Â | low | 117 | 7.044 | Â |
Multinodular | yes | 45 | 7.325 | 0.093 |
| Â | no | 176 | 7.103 | Â |
Cirrhosis | yes | 203 | 7.172 | 0.136 |
| Â | no | 18 | 6.883 | Â |